Emergence of monkeypox: a worldwide public health crisis

[1]  R. Knight,et al.  Wastewater surveillance for public health , 2023, Science.

[2]  F. Mohammadi-Moghadam,et al.  A systematic review on environmental perspectives of monkeypox virus , 2023, Reviews on environmental health.

[3]  D. Sano,et al.  Multiple traces of monkeypox detected in non-sewered wastewater with sparse sampling from a densely populated metropolitan area in Asia , 2022, The Science of the total environment.

[4]  R. P. Vivek-Ananth,et al.  In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs , 2022, Molecular Diversity.

[5]  M. G. Babashkina,et al.  In silico analyses of betulin: DFT studies, corrosion inhibition properties, ADMET prediction, and molecular docking with a series of SARS-CoV-2 and monkeypox proteins , 2022, Structural Chemistry.

[6]  N. Maffulli,et al.  Monkeypox: An Emerging Global Public Health Emergency , 2022, Life.

[7]  S. Mazzoli,et al.  Monkeypox: EpiMPX Surveillance System and Open Data with a Special Focus on European and Italian Epidemic , 2022, Journal of clinical virology plus.

[8]  Prosun Bhattacharya,et al.  Monkeypox outbreak: Wastewater and environmental surveillance perspective , 2022, Science of The Total Environment.

[9]  K. Thai,et al.  Identification of Diosmin and Flavin Adenine Dinucleotide as Repurposing Treatments for Monkeypox Virus: A Computational Study , 2022, International journal of molecular sciences.

[10]  Hisham N. Altayb.  Fludarabine, a Potential DNA-Dependent RNA Polymerase Inhibitor, as a Prospective Drug against Monkeypox Virus: A Computational Approach , 2022, Pharmaceuticals.

[11]  A. Rodríguez-Morales,et al.  Preventing the Next Pandemic: Is Live Vaccine Efficacious against Monkeypox, or Is There a Need for Killed Virus and mRNA Vaccines? , 2022, Vaccines.

[12]  S. Chhibber,et al.  Insights into the Monkeypox virus: making of another pandemic within the pandemic? , 2022, Environmental microbiology.

[13]  K. Dhama,et al.  Monkeypox reported in India – South East Asia Region: Health and economic challenges , 2022, The Lancet Regional Health - Southeast Asia.

[14]  M. Barbagallo,et al.  Human Monkeypox: A Comprehensive Narrative Review and Analysis of the Public Health Implications , 2022, Microorganisms.

[15]  P. Patel.  Monkeypox is Declared as a Global Health Emergency. Are We Prepared? , 2022, National Journal of Community Medicine.

[16]  D. K. Bonilla-Aldana,et al.  Phylogenomic analysis of the monkeypox virus (MPXV) 2022 outbreak: Emergence of a novel viral lineage? , 2022, Travel medicine and infectious disease.

[17]  J. Blanco,et al.  Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  J. Kaler,et al.  Monkeypox: A Comprehensive Review of Transmission, Pathogenesis, and Manifestation , 2022, Cureus.

[19]  D. Zucman,et al.  Monkeypox virus: A novel sexually transmitted disease? A case report from France , 2022, Travel medicine and infectious disease.

[20]  M. Delpino,et al.  Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countries , 2022, GeroScience.

[21]  A. Rodríguez-Morales,et al.  Monkeypox outbreaks during COVID-19 pandemic: are we looking at an independent phenomenon or an overlapping pandemic? , 2022, Annals of clinical microbiology and antimicrobials.

[22]  J. Kong,et al.  Epidemiological trends and clinical features of the ongoing monkeypox epidemic: A preliminary pooled data analysis and literature review , 2022, Journal of medical virology.

[23]  K. Dhama,et al.  Unexpected sudden rise of human monkeypox cases in multiple non-endemic countries amid COVID-19 pandemic and salient counteracting strategies: Another potential global threat? , 2022, International Journal of Surgery.

[24]  A. Rodríguez-Morales,et al.  Is monkeypox another reemerging viral zoonosis with many animal hosts yet to be defined? , 2022, The veterinary quarterly.

[25]  G. Lippi,et al.  Prevention and Treatment of Monkeypox , 2022, Drugs.

[26]  H. Gendelman,et al.  The 2022 outbreak and the pathobiology of the monkeypox virus , 2022, Journal of autoimmunity.

[27]  Vikram Thakur,et al.  Monkeypox virus (MPX) in humans a concern: Trespassing the global boundaries – Correspondence , 2022, International journal of surgery.

[28]  A. Winston,et al.  Transmission of monkeypox virus through sexual contact – A novel route of infection , 2022, The Journal of infection.

[29]  U. Awan,et al.  Monkeypox: A new threat at our doorstep! , 2022, The Journal of infection.

[30]  R. Kock,et al.  COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England , 2022, The Lancet Infectious Diseases.

[31]  Jennifer L. Small,et al.  Clinical features and management of human monkeypox: a retrospective observational study in the UK , 2022, The Lancet. Infectious diseases.

[32]  A. Rodríguez-Morales,et al.  The never-ending global emergence of viral zoonoses after COVID-19? The rising concern of monkeypox in Europe, North America and beyond , 2022, Travel Medicine and Infectious Disease.

[33]  Caroline A. Schrodt,et al.  Monkeypox in a Traveler Returning from Nigeria — Dallas, Texas, July 2021 , 2022, MMWR. Morbidity and mortality weekly report.

[34]  G. Wortmann,et al.  Imported Monkeypox from International Traveler, Maryland, USA, 2021 , 2022, Emerging infectious diseases.

[35]  F. Lienert,et al.  The changing epidemiology of human monkeypox—A potential threat? A systematic review , 2021, medRxiv.

[36]  H. Adler,et al.  Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021 , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[37]  A. Fontanet,et al.  Genomic history of human monkey pox infections in the Central African Republic between 2001 and 2018 , 2021, Scientific Reports.

[38]  U. Moens,et al.  Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution , 2020, Viruses.

[39]  T. Yeo,et al.  Imported Monkeypox, Singapore , 2020, Emerging infectious diseases.

[40]  J. Dunning,et al.  Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018 , 2020, Emerging infectious diseases.

[41]  C. Ihekweazu,et al.  Importance of epidemiological research of monkeypox: is incidence increasing? , 2020, Expert review of anti-infective therapy.

[42]  David H. Evans,et al.  Cytoplasmic factories, virus assembly, and DNA replication kinetics collectively constrain the formation of poxvirus recombinants , 2020, PloS one.

[43]  D. Delaune,et al.  Drug Development against Smallpox: Present and Future , 2020, Antimicrobial Agents and Chemotherapy.

[44]  Andrew T. Russo,et al.  Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge , 2019, Vaccine.

[45]  V. Munster,et al.  Nosocomial Transmission of Emerging Viruses via Aerosol-Generating Medical Procedures , 2019, Viruses.

[46]  C. Ihekweazu,et al.  The 2017 human monkeypox outbreak in Nigeria—Report of outbreak experience and response in the Niger Delta University Teaching Hospital, Bayelsa State, Nigeria , 2019, PloS one.

[47]  S. Eyangoh,et al.  Monkeypox virus phylogenetic similarities between a human case detected in Cameroon in 2018 and the 2017-2018 outbreak in Nigeria , 2019, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[48]  G. Ippolito,et al.  Monkeypox — Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era , 2018, International Journal of Infectious Diseases.

[49]  B. Monroe,et al.  Vaccinating against monkeypox in the Democratic Republic of the Congo , 2018, Antiviral Research.

[50]  Marc Van Ranst,et al.  Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans , 2018, Front. Public Health.

[51]  Ousmane Faye,et al.  Reemergence of Human Monkeypox in Nigeria, 2017 , 2018, Emerging infectious diseases.

[52]  R. Doshi,et al.  Strengthening of Surveillance during Monkeypox Outbreak, Republic of the Congo, 2017 , 2018, Emerging infectious diseases.

[53]  J. Muyembe,et al.  Maternal and Fetal Outcomes Among Pregnant Women With Human Monkeypox Infection in the Democratic Republic of Congo , 2017, The Journal of infectious diseases.

[54]  M. Mizuguchi,et al.  A Single Vaccination of Nonhuman Primates with Highly Attenuated Smallpox Vaccine, LC16m8, Provides Long-term Protection against Monkeypox. , 2017, Japanese journal of infectious diseases.

[55]  E. Filippova.  Antiviral Activity of Lady’s Mantle (Alchemilla vulgaris L.) Extracts against Orthopoxviruses , 2017, Bulletin of Experimental Biology and Medicine.

[56]  M. Pal,et al.  Epidemiology, Diagnosis, and Control of Monkeypox Disease: A comprehensive Review , 2017 .

[57]  T. Tippin,et al.  Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies , 2016, Therapeutic drug monitoring.

[58]  L. Nolen,et al.  Extended Human-to-Human Transmission during a Monkeypox Outbreak in the Democratic Republic of the Congo , 2016, Emerging infectious diseases.

[59]  A. A. Sergeev,et al.  New effective chemically synthesized anti-smallpox compound NIOCH-14. , 2016, The Journal of general virology.

[60]  W. Bower,et al.  Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident. , 2015, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[61]  O. Barth,et al.  Negative and Positive Staining in Transmission Electron Microscopy for Virus Diagnosis , 2015 .

[62]  D. Pickup.  Extracellular Virions: The Advance Guard of Poxvirus Infections , 2015, PLoS pathogens.

[63]  R. Lynfield,et al.  Clinical guidance for smallpox vaccine use in a postevent vaccination program. , 2015, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[64]  D. Florescu,et al.  Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses , 2014, Expert review of anti-infective therapy.

[65]  Jeffrey R. Kugelman,et al.  Genomic Variability of Monkeypox Virus among Humans, Democratic Republic of the Congo , 2014, Emerging infectious diseases.

[66]  J. J. van den Oord,et al.  KAY-2-41, a Novel Nucleoside Analogue Inhibitor of Orthopoxviruses In Vitro and In Vivo , 2013, Antimicrobial Agents and Chemotherapy.

[67]  B. Moss.  Poxvirus DNA replication. , 2013, Cold Spring Harbor perspectives in biology.

[68]  R. Buller,et al.  A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012. , 2013, Future virology.

[69]  Y. Nakazawa,et al.  Phylogenetic and Ecologic Perspectives of a Monkeypox Outbreak, Southern Sudan, 2005 , 2013, Emerging infectious diseases.

[70]  B. Moss.  Poxvirus Cell Entry: How Many Proteins Does it Take? , 2012, Viruses.

[71]  Sophie Duraffour,et al.  Mutations Conferring Resistance to Viral DNA Polymerase Inhibitors in Camelpox Virus Give Different Drug-Susceptibility Profiles in Vaccinia Virus , 2012, Journal of Virology.

[72]  I. Damon,et al.  In Vitro Characterization of a Nineteenth-Century Therapy for Smallpox , 2012, PloS one.

[73]  A. Freeman,et al.  Detection of molluscum contagiosum virus (MCV) DNA in the plasma of an immunocompromised patient and possible reduction of MCV DNA with CMX-001. , 2012, The Journal of infectious diseases.

[74]  I. Damon.  Status of human monkeypox: clinical disease, epidemiology and research. , 2011, Vaccine.

[75]  I. Damon,et al.  Monkeypox Disease Transmission in an Experimental Setting: Prairie Dog Animal Model , 2011, PloS one.

[76]  A. Gaspari,et al.  Efficacy of intravenous cidofovir in the treatment of giant molluscum contagiosum in a patient with human immunodeficiency virus. , 2011, Archives of dermatology.

[77]  R. Jordan,et al.  Development of the small-molecule antiviral ST-246 as a smallpox therapeutic. , 2011, Future virology.

[78]  R. Jordan,et al.  Development of ST-246® for Treatment of Poxvirus Infections , 2010, Viruses.

[79]  E. Zumbrun,et al.  ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile , 2010, Drug design, development and therapy.

[80]  K. B. Petersen,et al.  A POX‐LIKE DISEASE IN CYNOMOLGUS MONKEYS , 2009 .

[81]  K. Tyler.  Emerging viral infections of the central nervous system: part 1. , 2009, Archives of neurology.

[82]  A. MacNeil,et al.  Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[83]  R. Jordan,et al.  In Vitro Efficacy of ST246 against Smallpox and Monkeypox , 2008, Antimicrobial Agents and Chemotherapy.

[84]  S. Weber,et al.  Severe eczema vaccinatum in a household contact of a smallpox vaccinee. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[85]  J. Kennedy,et al.  ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine , 2008, Expert opinion on investigational drugs.

[86]  Wendy C. Magee,et al.  Cidofovir and (S)-9-[3-Hydroxy-(2-Phosphonomethoxy)Propyl]Adenine Are Highly Effective Inhibitors of Vaccinia Virus DNA Polymerase When Incorporated into the Template Strand , 2007, Antimicrobial Agents and Chemotherapy.

[87]  B. Moss,et al.  Colocalization of transcription and translation within cytoplasmic poxvirus factories coordinates viral expression and subjugates host functions. , 2007, Cell host & microbe.

[88]  A. Nitsche,et al.  Fast and reliable diagnostic methods for the detection of human poxvirus infections , 2007 .

[89]  R. Buller,et al.  Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice. , 2007, Antiviral research.

[90]  Ronald J. Moore,et al.  Protein composition of the vaccinia virus mature virion. , 2007, Virology.

[91]  S. Hughes,et al.  The history of N-methanocarbathymidine: the investigation of a conformational concept leads to the discovery of a potent and selective nucleoside antiviral agent. , 2006, Antiviral research.

[92]  J. Melski,et al.  Monkeypox: An epidemiologic and clinical comparison of African and US disease , 2006, Journal of the American Academy of Dermatology.

[93]  T. Mizutani,et al.  LC16m8, a Highly Attenuated Vaccinia Virus Vaccine Lacking Expression of the Membrane Protein B5R, Protects Monkeys from Monkeypox , 2006, Journal of Virology.

[94]  R. Jordan,et al.  An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge , 2005, Journal of Virology.

[95]  P. Formenty,et al.  Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. , 2005, The American journal of tropical medicine and hygiene.

[96]  R. Moyer,et al.  Classification of Poxviruses and Brief Characterization of the Genus Orthopoxvirus , 2005 .

[97]  B. Ligon.  Monkeypox: A review of the history and emergence in the Western hemisphere , 2004, Seminars in Pediatric Infectious Diseases.

[98]  J. Atwood,et al.  Smallpox vaccination and myopericarditis: a clinical review. , 2004, Journal of the American College of Cardiology.

[99]  P. Eckburg,et al.  Human monkeypox , 2004, The Lancet. Infectious diseases.

[100]  J. P. Davis,et al.  The detection of monkeypox in humans in the Western Hemisphere. , 2004, The New England journal of medicine.

[101]  M. Krathwohl,et al.  Rates and risks of transmission of smallpox and mechanisms of prevention. , 2003, The Journal of laboratory and clinical medicine.

[102]  M. Bray,et al.  Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections , 2003, Antiviral research.

[103]  E. A. Uvarova,et al.  Analysis of the Monkeypox Virus Genome , 2002, Virology.

[104]  E. De Clercq.  Cidofovir in the treatment of poxvirus infections , 2002, Antiviral research.

[105]  P. Jahrling,et al.  The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis) , 2001, Laboratory Investigation.

[106]  E. A. Uvarova,et al.  Human monkeypox and smallpox viruses: genomic comparison , 2001, FEBS letters.

[107]  D. Smee,et al.  Antiviral Activity and Mode of Action Studies of Ribavirin and Mycophenolic Acid against Orthopoxviruses in Vitro , 2001, Antiviral chemistry & chemotherapy.

[108]  P. Jahrling,et al.  Countermeasures to the Reemergence of Smallpox Virus as an Agent of Bioterrorism , 2000 .

[109]  C. King.  Hunter's Tropical Medicine and Emerging Infectious Diseases, 8th Edition:Hunter's Tropical Medicine and Emerging Infectious Diseases, 8th Edition , 2000 .

[110]  P E Fine,et al.  The transmission potential of monkeypox virus in human populations. , 1988, International journal of epidemiology.

[111]  I. Arita,et al.  Human monkeypox, 1970-79. , 1980, Bulletin of the World Health Organization.

[112]  H. Wenner,et al.  Monkeypox virus , 1973, Bacteriological reviews.

[113]  G. Appleyard,et al.  An antigenic difference between intracellular and extracellular rabbitpox virus. , 1971, The Journal of general virology.

[114]  P. A. Young,et al.  Prophylaxis of smallpox with methisazone. , 1969, American journal of epidemiology.

[115]  D. Huxsoll,et al.  Monkeypox: experimental infection in chimpanzee (Pan satyrus) and immunization with vaccinia virus. , 1968, American journal of veterinary research.

[116]  K. Mccarthy,et al.  The viruses of variola, vaccina, cowpox and ectromelia. Neutralization tests on the chorio-allantois with unabsorbed and absorbed immune sera. , 1950, British journal of experimental pathology.